2024-07-24 19:00:03
In partnership with Arcturus Therapeutics, a global late-stage clinical mRNA medicines and vaccines company, CSL received approval by Japan’s Ministry of Health, Labor and Welfare (MHLW), for ARCT-154, a self-amplifying mRNA (sa-mRNA) COVID-19 vaccine for initial vaccination and booster for adults 18 years and older in Japan.
With the approval of ARCT-154, CSL now offers an even more comprehensive portfolio of innovative vaccines that combat respiratory viral diseases.
What is Messenger RNA?
Messenger RNA (mRNA) vaccines help protect against infectious diseases by providing a blueprint for cells in the body to make a protein to help our immune systems recognize and fight the disease.
Different from standard mRNA vaccines, self-amplifying-mRNA vaccines instruct the body to make more mRNA and protein to achieve a higher immune response. Self-amplifying mRNA vaccines contain a smaller dose of mRNA yet yield a strong immune response.
2024-09-20 12:35:03 EAST RUTHERFORD, N.J. -- — Aaron Rodgers was in total control in a…
New Delhi: Designer-actor Masaba Gupta, in a recent interview talked about being harassed in school…
KUALA LUMPUR, Malaysia -- Malaysian police on Thursday detained the CEO and other top leaders…
2024-09-20 12:15:03 The Sun Belt Conference season kicks off on Thursday when the South Alabama…
2024-09-20 12:05:03 The exciting Appalachian State Mountaineers face the South Alabama Jaguars trying to clock…
2024-09-20 11:55:02 Palworld, colloquially known to fans as “Pokémon with guns,” is in hot water.…